Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00490503 · ClinicalTrials.gov registry record
Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy Techniques (MRS) for Assessing Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 20
- Enrollment target
NCT00490503: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00490503 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00490503 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if magnetic resonance imaging (MRI) with magnetic resonance spectroscopy (MRS) can show the effects of pre-surgical chemotherapy in breast cancer patients who are eligible to receive preoperative chemotherapy.
Interventions
- PROCEDURE Magnetic Resonance Imaging (MRI)
- PROCEDURE Magnetic Resonance Spectroscopy (MRS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2006-10-25 |
| Est. Completion | 2022-10-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00490503
The ClinicalTrials.gov registry entry for NCT00490503 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT00490503 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00490503 about?
NCT00490503 is a clinical study titled "Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy Techniques (MRS) for Assessing Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer". The goal of this clinical research study is to learn if magnetic resonance imaging (MRI) with magnetic resonance spectroscopy (MRS) can show the effects of pre-surgical chemotherapy in breast cancer patients who are eligible to receive preoperative chemotherapy.
What is the current status of trial NCT00490503?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2006-10-25. Estimated completion is 2022-10-18.
What interventions are being tested in trial NCT00490503?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (PROCEDURE), Magnetic Resonance Spectroscopy (MRS) (PROCEDURE).
Who is sponsoring clinical trial NCT00490503?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.